Search - tctmd.com

Displaying 621 - 640 of 1431

Sort: Relevancy | Date

News Daily News

Un Estudio Explora los Predictores de No Curación en Pacientes ICE Tras Tratamiento Endovascular

Caitlin E. Cox

September 02, 2014

News Industry News

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

September 02, 2014

News Daily News

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

September 02, 2014

News Daily News

Study Explores Predictors of Nonhealing in CLI Patients After Endovascular Therapy

Caitlin E. Cox

September 02, 2014

News Daily News

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

L.A. McKeown

September 02, 2014

News Daily News

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

Todd Neale

September 02, 2014

News Daily News

La Alta Reactividad a la Aspirina Justo Antes de la PCI se asocia a Peores Resultados

September 02, 2014

News Daily News

HORIZONS-AMI亚组研究：直接PCI后抗凝血产生的结果更差

September 02, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

News Daily News

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

September 02, 2014

News Conference News ESC 2014

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

Caitlin E. Cox

September 02, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Conference News ESC 2014

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Yael L. Maxwell

August 31, 2014

News Industry News

Large-scale Study Confirms Growing Body of Clinical Evidence for the St. Jude Medical Quadripolar System

August 31, 2014

News Conference News ESC 2014

APOLLO: Worse Long-Term Outcomes in American vs European Survivors of Acute MI

Yael L. Maxwell

August 31, 2014

News Conference News ESC 2014

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Todd Neale

August 30, 2014

News Industry News

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

August 28, 2014

News Industry News

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

August 27, 2014

News Industry News

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

August 25, 2014

News Daily News

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Todd Neale

August 22, 2014

Advertisement

Un Estudio Explora los Predictores de No Curación en Pacientes ICE Tras Tratamiento Endovascular

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

Study Explores Predictors of Nonhealing in CLI Patients After Endovascular Therapy

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

La Alta Reactividad a la Aspirina Justo Antes de la PCI se asocia a Peores Resultados

HORIZONS-AMI亚组研究：直接PCI后抗凝血产生的结果更差

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Large-scale Study Confirms Growing Body of Clinical Evidence for the St. Jude Medical Quadripolar System

APOLLO: Worse Long-Term Outcomes in American vs European Survivors of Acute MI

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content